Structured intermittent treatment for HIV disease: Necessary concession or premature compromise?

Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):4-6. doi: 10.1073/pnas.022629399.
No abstract available

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Clinical Trials as Topic
  • HIV Infections / immunology
  • HIV Infections / mortality
  • HIV Infections / therapy*
  • Humans
  • Time Factors

Substances

  • Anti-HIV Agents